BHA issue notice, regarding Regumate Equine, to British racehorse Trainers

On 11 September  the BHA published a Notice regarding the use of products which contain altrenogest – a copy of this notice can be found on the BHA website.

At the time of publication, the BHA obtained samples from several different batch numbers of Regumate® Equine 2.2mg/ml Oral Solution for Horses (MSD Animal Health) and requested analysis of these samples from LGC, our partner analytical laboratory. The results of this analysis detected the presence of trendione in the above batches of Regumate® Equine. Continue reading